SION (SION) reported EBIT of -$29.6M in Q1 2026.

How has SION's EBIT changed year-over-year?

SION's EBIT decreased by 50.6% year-over-year, from -$19.66M to -$29.6M.

Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.

SION SION EBIT

EBIT at other companies

Septerna, Inc.SEPN

-$13.3M+48.7%

BioCryst PharmaceuticalsBCRX

-$701.6M-3,405%

Denali Therapeutics Inc.DNLI

-$137.36M+5.6%

Vertex PharmaceuticalsVRTX

——

AbbVieABBV

——

Neurocrine BiosciencesNBIX

——

Other financials

Income statement

See full

Operating income-$29.6M-50.6%

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.86B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Calculated from SION’s reported figures.

−$29.6Moperating income=-$29.6M

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's EBIT?: SION (SION) reported EBIT of -$29.6M in Q1 2026.
How has SION's EBIT changed year-over-year?: SION's EBIT decreased by 50.6% year-over-year, from -$19.66M to -$29.6M.
What does EBIT mean?: Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.